169 related articles for article (PubMed ID: 27706622)
41. Investigation on the association between IL-10 C819T gene polymorphisms and susceptibility to gastric cancer.
Li L; Tang XY; Ye LM; Yang Q; Li Y
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002581
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms of the TLR4 gene and risk of gastric cancer.
Huang L; Yuan K; Liu J; Ren X; Dong X; Tian W; Jia Y
Gene; 2014 Mar; 537(1):46-50. PubMed ID: 24365597
[TBL] [Abstract][Full Text] [Related]
43. Impact of
Yan K; Wu K; Lin C; Jie Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31416884
[TBL] [Abstract][Full Text] [Related]
44. The relationship between five non-synonymous polymorphisms within three XRCC genes and gastric cancer risk in a Han Chinese population.
Gong H; Li H; Zou J; Mi J; Liu F; Wang D; Yan D; Wang B; Zhang S; Tian G
Tumour Biol; 2016 May; 37(5):5905-10. PubMed ID: 26590607
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population.
Shen H; Xu Y; Qian Y; Yu R; Qin Y; Zhou L; Wang X; Spitz MR; Wei Q
Int J Cancer; 2000 Nov; 88(4):601-6. PubMed ID: 11058877
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population.
Yuan LJ; Jin TB; Yin JK; Du XL; Wang Q; Dong R; Wang SZ; Cui Y; Chen C; Lu JG
Cancer Epidemiol; 2012 Dec; 36(6):e366-72. PubMed ID: 22796266
[TBL] [Abstract][Full Text] [Related]
47. Correlation between Interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population.
Yang LJ; Gao W; Bai JY; Zhang XK; Han X; Sun YH; Zhang LL; Zhang MM
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1271-82. PubMed ID: 27097946
[TBL] [Abstract][Full Text] [Related]
48. [The association of XRCC2 gene polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in China].
Wang N; Dong XJ; Li Y; Guo W; Zhou RM; Zhang XJ; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):538-43. PubMed ID: 17922422
[TBL] [Abstract][Full Text] [Related]
49. Association of XRCC1 gene polymorphisms with susceptibility to gastric cancer in Chinese Han population.
Meng H; Lu S; Zhang Z; Chen M; Li C; Liu L; Luan Y
J Pharm Pharmacol; 2014 Oct; 66(10):1463-8. PubMed ID: 24779987
[TBL] [Abstract][Full Text] [Related]
50. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
[TBL] [Abstract][Full Text] [Related]
51. Genetic variations in the SMAD4 gene and gastric cancer susceptibility.
Wu DM; Zhu HX; Zhao QH; Zhang ZZ; Wang SZ; Wang ML; Gong WD; Tan M; Zhang ZD
World J Gastroenterol; 2010 Nov; 16(44):5635-41. PubMed ID: 21105199
[TBL] [Abstract][Full Text] [Related]
52.
Yuan L; Hu WM; Chen K; Shi Q; Lin A; Chen HT; Zhuo ZJ; Zeng L
Br J Biomed Sci; 2021 Jul; 78(3):135-140. PubMed ID: 33393424
[No Abstract] [Full Text] [Related]
53. ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.
Chen J; Xie F; Chen K; Wang D; Jiang H; Li J; Pan F; Chen S; Zhang Y; Ruan Z; Huang H; Zou L; Liang H
Cancer Biol Ther; 2009 Jul; 8(14):1424-30. PubMed ID: 19458483
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
55. Association of CD14/-260 polymorphism with gastric cancer risk in Highland Tibetans.
Li K; Dan Z; Hu XJ; Gesang LB; Ze YG; Bianba ZX; Ciren CM; Nie YQ
World J Gastroenterol; 2014 Mar; 20(10):2688-94. PubMed ID: 24627605
[TBL] [Abstract][Full Text] [Related]
56. Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population.
Qiao W; Wang T; Zhang L; Tang Q; Wang D; Sun H
Int J Biol Sci; 2013; 9(7):753-8. PubMed ID: 23983608
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
[TBL] [Abstract][Full Text] [Related]
58. TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population.
Li H; Liu Q; Hou S; Du L; Zhou Q; Zhou Y; Kijlstra A; Li Z; Yang P
Hum Genet; 2013 Mar; 132(3):293-300. PubMed ID: 23161053
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.
Lu Y; Xu YC; Shen J; Yu RB; Niu JY; Guo JT; Hu X; Shen HB
World J Gastroenterol; 2005 Jan; 11(1):56-60. PubMed ID: 15609397
[TBL] [Abstract][Full Text] [Related]
60. TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
Wang X; Xue L; Yang Y; Xu L; Zhang G
PLoS One; 2013; 8(6):e65731. PubMed ID: 23776537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
